just two weeks after Merck pulled its painkiller, Vioxx, which is in the same class of drugs as Bextra, from the market because a study showed.
Since the Merck decision, public health advocates and some congressional leaders have asked pointedly why the FDA, the nation arbiter of drug safety, did not act sooner itself.
The turbulence outside the aircraft was an echo of the corporate tempest leading up to their trip.
Over the years, evidence has slowly accumulated consistent with that hypothesis.
